Trials / Sponsors / Prof. Dr. med. Dirk Schadendorf
Prof. Dr. med. Dirk Schadendorf
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanom Malignant Melanoma | Phase 1 / Phase 2 | 2018-04-24 |
| Terminated | Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma Malignant Melanoma | Phase 2 | 2015-11-01 |
| Completed | Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED Malignant Melanoma | Phase 2 | 2015-09-02 |
| Completed | Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic M Cutaneous Malignant Melanoma | Phase 1 / Phase 2 | 2015-03-17 |
| Completed | Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Ob Merkel Cell Carcinoma | Phase 2 | 2014-06-01 |
| Completed | THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease Ocular Melanoma | Phase 2 | 2011-10-01 |